Literature DB >> 8504307

Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe.

A M Leahey1, L R Charnas, R L Nussbaum.   

Abstract

A candidate gene, OCRL-1, for the oculocerebrorenal syndrome of Lowe (OCRL) has been identified via positional cloning strategies. We have now developed RT-PCR techniques which allow amplification of nearly all of the open reading frame from total RNA and have used the PCR products for mutational analysis. Single strand conformational polymorphism analysis detected aberrant migration in two unrelated patients, both of whom were shown to have the same nonsense mutation at base 2746 on direct sequencing. An additional patient was found to be missing a segment from his RNA that corresponds to an entire exon. The identification of mutations in the OCRL-1 gene provides strong genetic evidence for its being the gene involved in Lowe syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504307     DOI: 10.1093/hmg/2.4.461

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  23 in total

1.  Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.

Authors:  Susan P Bothwell; Emily Chan; Isa M Bernardini; Yien-Ming Kuo; William A Gahl; Robert L Nussbaum
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

2.  Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.

Authors:  P A Jänne; S F Suchy; D Bernard; M MacDonald; J Crawley; A Grinberg; A Wynshaw-Boris; H Westphal; R L Nussbaum
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

3.  Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.

Authors:  T Lin; B M Orrison; A M Leahey; S F Suchy; D J Bernard; R A Lewis; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

4.  The genome of Caenorhabditis elegans.

Authors:  R Waterston; J Sulston
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Characterization of a germline mosaicism in families with Lowe syndrome, and identification of seven novel mutations in the OCRL1 gene.

Authors:  V Satre; N Monnier; F Berthoin; C Ayuso; A Joannard; P S Jouk; I Lopez-Pajares; A Megabarne; H J Philippe; H Plauchu; M L Torres; J Lunardi
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

Review 6.  Genetic causes of hypercalciuric nephrolithiasis.

Authors:  Michael J Stechman; Nellie Y Loh; Rajesh V Thakker
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

Review 7.  Dent's disease.

Authors:  Olivier Devuyst; Rajesh V Thakker
Journal:  Orphanet J Rare Dis       Date:  2010-10-14       Impact factor: 4.123

8.  Localisation of a new gene for non-specific mental retardation to Xq22-q26 (MRX35).

Authors:  X X Gu; R Decorte; P Marynen; J P Fryns; J J Cassiman; P Raeymaekers
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

9.  The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.

Authors:  X Zhang; A B Jefferson; V Auethavekiat; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complex.

Authors:  I M Olivos-Glander; P A Jänne; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.